InsiderTrades

Form 4 for ICE Intercontinental Exchange

Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-19 · accession 0001193125-25-291486 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-11-21 2025-11-19 ICE Surdykowski Andrew J GC S - Sale+OE $152.52 -1,770 44.2K -4% -$270.0K
DT 2025-11-21 2025-11-19 ICE Surdykowski Andrew J GC M - OptEx $50.01 +1,770 46.0K +4% +$88.5K
DT 2025-11-21 2025-11-19 ICE Surdykowski Andrew J GC M - OptEx $0.00 -1,770 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-19 S D 1,770 $152.52 44,212 D — — (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024. (F3) The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year EBITDA PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. (F4) The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. (F2) The common stock number referred in Table I is an aggregate number and represents 35,318 shares of common stock, 3,141 unvested restricted stock units ("RSUs"), and 5,753 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
2 Common Common Stock 2025-11-19 M A 1,770 $50.01 45,982 D — — (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024.
3 Derivative Employee Stock Option (right to buy) Holding 2025-11-19 M D 1,770 $0.00 0 D $50.01 · — to 2026-01-14 1,770 Common Stock (F5) These options are fully vested.